These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1027 related items for PubMed ID: 22288302

  • 21. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
    Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME.
    Headache; 2006 May; 46(5):766-72. PubMed ID: 16643579
    [Abstract] [Full Text] [Related]

  • 22. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
    Takeshima T.
    Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
    [Abstract] [Full Text] [Related]

  • 23. Probable medication-overuse headache: the effect of a 2-month drug-free period.
    Zeeberg P, Olesen J, Jensen R.
    Neurology; 2006 Jun 27; 66(12):1894-8. PubMed ID: 16707727
    [Abstract] [Full Text] [Related]

  • 24. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.
    J Neurol Sci; 2013 Aug 15; 331(1-2):48-56. PubMed ID: 23790235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical aspects of medication overuse headaches.
    Da Silva AN, Lake AE.
    Headache; 2014 Jan 15; 54(1):211-7. PubMed ID: 24116964
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical considerations on chronic migraine, pharmacoresistance and refractoriness.
    Bussone G.
    Neurol Sci; 2010 Jun 15; 31 Suppl 1():S83-5. PubMed ID: 20464591
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.
    Zeeberg P, Olesen J, Jensen R.
    Cephalalgia; 2006 Oct 15; 26(10):1192-8. PubMed ID: 16961785
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB.
    Cephalalgia; 2007 Mar 15; 27(3):230-4. PubMed ID: 17263770
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medication overuse headache: biobehavioral issues and solutions.
    Lake AE.
    Headache; 2006 Oct 15; 46 Suppl 3():S88-97. PubMed ID: 17034403
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.